Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
J Investig Allergol Clin Immunol
    February 2024
  1. SOUSA-PINTO B, Palamarchuk Y, Leemann L, Jankin S, et al
    From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
    J Investig Allergol Clin Immunol. 2024;34:12-19.
    >> Share

  2. PILIA MF, Espejo D, Soler D, Munoz X, et al
    Occupational Asthma due to alumina exposure.
    J Investig Allergol Clin Immunol. 2024 Feb 20:0. doi: 10.18176/jiaci.0974.
    >> Share

  3. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY. Grade of awareness of Spanish allergist, hospital pharmacist, and pulmonologists on the relevance of bronchial epithelium and alarmins in the pathogenesis and management of severe asthma.
    J Investig Allergol Clin Immunol. 2024 Feb 14:0. doi: 10.18176/jiaci.0997.
    >> Share

  4. PLAZA V, Trigueros JA, Carretero JA, Ojanguren Arranz I, et al
    The use of triple therapy in asthma. The GEMA-FORUM V task force.
    J Investig Allergol Clin Immunol. 2024 Feb 9:0. doi: 10.18176/jiaci.0975.
    >> Share

    January 2024
  5. DOMINGUEZ-ORTEGA J, Colas C, Delgado Romero J, Habernau Mena A, et al
    Basal clinical characteristics and phenoendotypes of patients with severe asthma in Alergodata: The Spanish Allergy Society Registry.
    J Investig Allergol Clin Immunol. 2024 Jan 12:0. doi: 10.18176/jiaci.0989.
    >> Share

    December 2023
  6. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as diagnostic criteria in Asthma-COPD overlap syndrome. Prevalence and characterization of the syndrome in a real-life asthma cohort.
    J Investig Allergol Clin Immunol. 2023 Dec 22:0. doi: 10.18176/jiaci.0966.
    >> Share

  7. BETANCOR D, Valverde-Monge M, Barroso B, Gomez-Lopez A, et al
    Non-asthmatic eosinophilic bronquitis review. A systematic review of current treatment options.
    J Investig Allergol Clin Immunol. 2023 Dec 19:0. doi: 10.18176/jiaci.0984.
    >> Share

  8. PAOLETTI G, Casini M, Malvezzi L, Pirola F, et al
    Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2023;33:457-463.
    >> Share

    October 2023
  9. NARVAEZ-FERNANDEZ E, Pose K, Caballero ML, Rodriguez-Perez R, et al
    Occupational asthma and food allergy due to soybean in a bakery worker.
    J Investig Allergol Clin Immunol. 2023 Oct 30:0. doi: 10.18176/jiaci.0958.
    >> Share

  10. ESPEJO D, Pilia F, Romero-Mesones C, Ojanguren I, et al
    Impact of obesity and lung function on the efficacy of biological treatment in patients with asthma.
    J Investig Allergol Clin Immunol. 2023 Oct 18:0. doi: 10.18176/jiaci.0941.
    >> Share

  11. MIRALLES-LOPEZ JC, Antolin-Amerigo D, Garcia-Moguel I, Dominguez-Ortega J, et al
    Positioning of Tezepelumab in severe asthma.
    J Investig Allergol Clin Immunol. 2023 Oct 9:0. doi: 10.18176/jiaci.0949.
    >> Share

    September 2023
  12. PEREZ DE LLANO L, Muniz Fernandez MC, Davila I
    Impact of the ERS/ATS 2021 guidelines for lung function interpretation on assessing the response to biologics in asthma.
    J Investig Allergol Clin Immunol. 2023 Sep 18:0. doi: 10.18176/jiaci.0943.
    >> Share

  13. BANTULA M, Arismendi E, Roca-Ferrer J, Picado C, et al
    IL-1R2 gene expression is downregulated in obesity-associated asthma.
    J Investig Allergol Clin Immunol. 2023 Sep 4:0. doi: 10.18176/jiaci.0928.
    >> Share

  14. JAFFUEL D, Serrano E, Leroyer C, Chartier A, et al
    SQ HDM sublingual immunotherapy tablet for the treatment of HDM allergic rhinitis and asthma improves subjective sleepiness and insomnia: an exploratory analysis of the real-life CARIOCA study.
    J Investig Allergol Clin Immunol. 2023 Sep 4:0. doi: 10.18176/jiaci.0934.
    >> Share

    June 2023
  15. GRANDA P, Villamanan E, Heinz S, Laorden D, et al
    Compassionate Use of Reslizumab in a Life-Threatening Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2023 Jun 21:0. doi: 10.18176/jiaci.0920.
    >> Share

  16. DE WIT J, Dalm VA, Totte JE, Kamphuis LS, et al
    Atopic Manifestations Are Underestimated Clinical Features in Various Primary Immunodeficiency Disease Phenotypes.
    J Investig Allergol Clin Immunol. 2023;33:200-208.
    >> Share

  17. ARISMENDI E, Cisneros C, Blanco-Aparicio M, Martinez-Moragon E, et al
    REDES study: Mepolizumab is effective in patients with severe asthma and comorbid nasal polyps.
    J Investig Allergol Clin Immunol. 2023 Jun 8:0. doi: 10.18176/jiaci.0905.
    >> Share

  18. KIM YH, Park MR, Kim SY, Kim MY, et al
    Respiratory microbiome profiles are associated with distinct inflammatory phenotype and lung function in children with asthma.
    J Investig Allergol Clin Immunol. 2023 Jun 1:0. doi: 10.18176/jiaci.0918.
    >> Share

  19. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting.
    J Investig Allergol Clin Immunol. 2023;33:217-219.
    >> Share

  20. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force.
    J Investig Allergol Clin Immunol. 2023;33:214-217.
    >> Share

    April 2023
  21. HAROUN-DIAZ E, Vazquez de la Torre M, Somoza ML, Blanca-Lopez N, et al
    Occupational Rhinitis Due to Coati Allergy and Cross-reactivity With Dog Serum Albumin.
    J Investig Allergol Clin Immunol. 2023;33:147-148.
    >> Share

    March 2023
  22. MORA T, Sanchez-Collado I, Mullol J, Ribo P, et al
    Prevalence of asthma in Catalonia (Spain): a retrospective, large-scale population-based study.
    J Investig Allergol Clin Immunol. 2023 Mar 24:0. doi: 10.18176/jiaci.0903.
    >> Share

    February 2023
  23. LOLI-AUSEJO D, Perdomo G, Mascaro B, Martinez-Olondris P, et al
    Mepolizumab treatment for severe eosinophilic asthma: a 5-years real-life experience.
    J Investig Allergol Clin Immunol. 2023 Feb 23:0. doi: 10.18176/jiaci.0898.
    >> Share

  24. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE sensitization to Blo t 21 and Blo t 5 is associated with asthma in the tropics: a case-control study.
    J Investig Allergol Clin Immunol. 2023 Feb 21:0. doi: 10.18176/jiaci.0892.
    >> Share

  25. MARQUES-MEJIAS MA, Tomas-Perez M, Hernandez-Martin I, Loli-Ausejo D, et al
    Recurrent Bronchospasm in Children Treated in the Emergency Department.
    J Investig Allergol Clin Immunol. 2023;33:49-51.
    >> Share

    January 2023
  26. MONTORO J, Antolin-Amerigo D, Izquierdo-Dominguez A, Zapata JJ, et al
    The impact of inhalers for asthma on the global climate: a systematic review of carbon footprint and clinical outcomes in Spain.
    J Investig Allergol Clin Immunol. 2023 Jan 17:0. doi: 10.18176/jiaci.0887.
    >> Share

  27. YEN-JUNG L, Hsin-Kuo K, Sheng-Wei P, Jia-Yih F, et al
    Airway reactance predicts static lung hyperinflation in severe asthma.
    J Investig Allergol Clin Immunol. 2023 Jan 16:0. doi: 10.18176/jiaci.0888.
    >> Share

    December 2022
  28. PEREZ DE LLANO L, Martinez Moragon E, Entrenas LM, Martinez Rivera C, et al
    Validation of the Asthma Impairment and Risk Questionnaire (AIRQ) in Spain: a useful tool to assess asthma control in adolescent and adult patients.
    J Investig Allergol Clin Immunol. 2022 Dec 15:0. doi: 10.18176/jiaci.0881.
    >> Share

  29. GIL-MARTINEZ M, Rodrigo-Munoz JM, Sastre B, Canas JA, et al
    Serum microRNAs Catalog Asthma Patients by Phenotype.
    J Investig Allergol Clin Immunol. 2022;32:471-478.
    >> Share

    November 2022
  30. HERRERA-LUIS E, Forno E, Celedon JC, Pino-Yanes M, et al
    Asthma exacerbations: the genes behind the scenes.
    J Investig Allergol Clin Immunol. 2022 Nov 24:0. doi: 10.18176/jiaci.0878.
    >> Share

  31. CASTILLA-MARTINEZ M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al
    Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0872.
    >> Share

  32. DOMINGO C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al
    Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0871.
    >> Share

  33. MIGUERES N, Vandenplas O, Walusiak-Skorupa J, Wiszniewska M, et al
    Sputum Inflammatory Patterns are Associated with Distinct Clinical Characteristics in Subjects with Occupational Asthma Independently from the Causal Agent.
    J Investig Allergol Clin Immunol. 2022 Nov 8:0. doi: 10.18176/jiaci.0868.
    >> Share

    October 2022
  34. BETANCOR D, Olaguibel JM, Rodrigo-Munoz JM, Alvarez Puebla MJ, et al
    Lung function abnormalities and their correlation with clinical characteristics and inflammatory markers in adult asthma.
    J Investig Allergol Clin Immunol. 2022 Oct 17:0. doi: 10.18176/jiaci.0866.
    >> Share

  35. ESTEBAN-GORGOJO I, Gorgojo MP, Sastre J, Garcia-Rio F, et al
    The influence of BMI in asthma. Which traits are due to obesity and which to asthma and obesity phenotype?
    J Investig Allergol Clin Immunol. 2022 Oct 6:0. doi: 10.18176/jiaci.0865.
    >> Share

    September 2022
  36. MOYA B, Huang C, Kjarsgaard M, Martin-Arriscado C, et al
    Exhaled breath temperature is not helpful to identify cellular bronchitis in severe asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 29:0. doi: 10.18176/jiaci.0862.
    >> Share

  37. BANTULA M, Tubita V, Roca-Ferrer J, Mullol J, et al
    Weight loss and vitamin D improve hyporesponsiveness to corticosteroids in obese asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 8:0. doi: 10.18176/jiaci.0861.
    >> Share

  38. MATUCCI A, Micheletto C, Vultaggio A
    Severe asthma and biologics: managing complex patients.
    J Investig Allergol Clin Immunol. 2022 Sep 1:0. doi: 10.18176/jiaci.0856.
    >> Share

    August 2022
  39. PEREZ DE LLANO L, Cisneros C, Dominguez-Ortega J, Martinez-Moragon E, et al
    Response to monoclonal antibodies in asthma: definitions, potential reasons for failure and therapeutic options for suboptimal response.
    J Investig Allergol Clin Immunol. 2022 Aug 30:0. doi: 10.18176/jiaci.0857.
    >> Share

  40. MILGER K, Skowasch D, Hamelmann E, Mummler C, et al
    Bronchodilator reversibility in the GAN severe asthma cohort.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0850.
    >> Share

  41. MELERO MORENO C, Almonacid Sanchez C, Banas Conejero D, Quirce S, et al
    Understanding severe asthma through small and Big Data in Spanish hospitals - PAGE Study.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0848.
    >> Share

    June 2022
  42. OTANI T, Iwamoto H, Horimasu Y, Yamaguchi K, et al
    Effect of dupilumab in a patient with severe asthma complicated with recurrent anaphylaxis: a case report.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0840.
    >> Share

  43. ALMONACID SANCHEZ C, Blanco-Aparicio M, Dominguez-Ortega J, Giner Donaire J, et al
    Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0841.
    >> Share

  44. PEREZ DE LLANO LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al
    First line versus second line use of reslizumab in severe uncontrolled asthma.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0839.
    >> Share

  45. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    >> Share

  46. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    >> Share

  47. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.
    >> Share

    May 2022
  48. GONZALEZ O, Picado C, Alobid I, Ramirez J, et al
    Eosinophilic sialodochitis: a rare comorbidity of severe asthma.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0817.
    >> Share

  49. DOMINGUEZ-ORTEGA J, Luna-Porta JA, Olaguibel JM, Barranco E, et al
    Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0816.
    >> Share

    April 2022
  50. IZQUIERDO E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, et al
    Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    J Investig Allergol Clin Immunol. 2022;32:81-96.
    >> Share

  51. URIARTE SA, Gronlund H, Wintersand A, Bronge J, et al
    Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2022;32:133-140.
    >> Share

  52. BARROSO B, Valverde-Monge M, Alobid I, Olaguibel JM, et al
    Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study.
    J Investig Allergol Clin Immunol. 2022 Apr 12:0. doi: 10.18176/jiaci.0812.
    >> Share

    March 2022
  53. SALOMONSSON M, Cardenas EI, Dahlin JS, Kalm-Stephens P, et al
    The proportion of FceRI+ blood monocytes increases with the degree of IgE sensitization in asthma.
    J Investig Allergol Clin Immunol. 2022 Mar 2:0. doi: 10.18176/jiaci.0797.
    >> Share

    February 2022
  54. MIRALLES LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, et al
    Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.
    J Investig Allergol Clin Immunol. 2022 Feb 11:0. doi: 10.18176/jiaci.0793.
    >> Share

    January 2022
  55. DELGADO ROMERO J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, et al
    Biological therapy at-home administration support for patients with severe asthma BioCart(c).
    J Investig Allergol Clin Immunol. 2022 Jan 24:0. doi: 10.18176/jiaci.0786.
    >> Share

  56. VALVERDE-MOLINA J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, et al
    Transition of adolescents with severe asthma from pediatric to adult care in Spain: the STAR consensus.
    J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0780.
    >> Share

    December 2021
  57. LEIRIA-PINTO P, Carreiro-Martins P, Peralta I, Marques J, et al
    Factors Associated With Asthma Control in 121 Preschool Children.
    J Investig Allergol Clin Immunol. 2021;31:471-480.
    >> Share

  58. DELGADO-ROMERO J, Pereyra-Rodriguez JJ
    Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era.
    J Investig Allergol Clin Immunol. 2021 Dec 13:0. doi: 10.18176/jiaci.0771.
    >> Share

    November 2021
  59. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    >> Share

  60. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    >> Share

  61. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    >> Share

  62. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    >> Share

    October 2021
  63. PACHOLCZAK-MADEJ R, Kuszmiersz P, Iwaniec T, Zareba L, et al
    Endothelial Dysfunction and Pentraxin-3 in Clinically Stable Adult Asthma Patients.
    J Investig Allergol Clin Immunol. 2021;31:417-425.
    >> Share

  64. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    >> Share

  65. LEAL M, Paciencia I, Farraia M, Cavaleiro Rufo J, et al
    Airborne Food Allergen and Aeroallergen Levels in Health Care Settings: An Unaccounted for but Potentially Relevant Source of Exposure?
    J Investig Allergol Clin Immunol. 2021;31:426-432.
    >> Share

    September 2021
  66. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    >> Share

    July 2021
  67. ALMONACID SANCHEZ C, Melero Moreno C, Quirce Gancedo S, Sanchez-Herrero MG, et al
    PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
    J Investig Allergol Clin Immunol. 2021;31:308-315.
    >> Share

    June 2021
  68. PEREZ DE LLANO L, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D, et al
    Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2021;31:268-270.
    >> Share

  69. JACOME C, Pereira R, Almeida R, Amaral R, et al
    Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT).
    J Investig Allergol Clin Immunol. 2021;31:270-273.
    >> Share

  70. BENZECRY V, Pravettoni V, Segatto G, Marzano AV, et al
    Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2021;31:261-263.
    >> Share

    April 2021
  71. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    >> Share

  72. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    >> Share

  73. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    >> Share

  74. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    >> Share

    February 2021
  75. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    >> Share

  76. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    >> Share

  77. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016